Trial Profile
A phase II study to evaluate the relationship between Tau Pathology and Progression of Alzheimer's Disease
Status:
Active, no longer recruiting
Phase of Trial:
Phase II
Latest Information Update: 09 Sep 2016
Price :
$35
*
At a glance
- Drugs Flortaucipir-F-18 (Primary)
- Indications Alzheimer's disease
- Focus Diagnostic use
- 09 Sep 2016 New trial record